Stress Hyperglycemia is Associated with Early Neurologic Deterioration in Patients with Acute Ischemic Stroke After Intravenous Thrombolysis Without Hemorrhagic Transformation

Overview

Journal Diabetol Metab Syndr

Publisher Biomed Central

Specialty Endocrinology

Date 2024 Nov 26

PMID 39587672

Authors

Junjie Lei

Yanfang Peng

Wenbin Li

Xiaofeng Chen

Qian Fan

Chenhao Liu

Chaogang Tang

Shijian Luo

Weihua Mai

Lei Zhang

Affiliations

Soon will be listed here.

Abstract

Background: This aimed to elucidate the impact of stress hyperglycemia on early neurological deterioration (END) in patients with acute non-cardiogenic cerebral infarction who did not experience hemorrhagic transformation following intravenous thrombolysis to identify risk factors associated with END.

Methods: This retrospective case-control study analyzed data from consecutive patients who received intravenous thrombolysis for acute ischemic stroke (AIS) without hemorrhagic transformation at the Stroke Center of The Fifth Affiliated Hospital of Sun Yat-sen University from January 2018 to February 2023. END was defined as an increase of more than 2 points on the National Institutes of Health Stroke Scale (NIHSS) within 7 days of admission.

Results: A total of 250 patients (56 males, 22.4%) were included, with a mean age of 63.34 ± 12.90 years. Of them, 41 were classified into the END group and 209 into the non-END group. Stress hyperglycemia ratio (SHR) demonstrated a significant correlation with END (r=-0.003, P = 0.003). HbA1c (OR = 0.68, 95% CI: 0.481-0.921) and SHR (OR = 0.00, 95% CI: 0.0-0.051) were independently associated with END. Receiver-operating characteristic (ROC) curve analysis indicated that SHR had a sensitivity of 79.9%, specificity of 88.8%, and an area under the curve (AUC) of 0.857 for predicting END.

Conclusions: SHR was significantly associated with END in patients with acute non-cardioembolic cerebral infarction who did not undergo hemorrhagic transformation after intravenous thrombolysis.

References

Jung H, Ryu J, Kim B, Kang D, Kwon S, Kim J . Time Window for Induced Hypertension in Acute Small Vessel Occlusive Stroke With Early Neurological Deterioration. Stroke. 2023; 55(1):14-21. DOI: 10.1161/STROKEAHA.123.044334. View

Shen Y, Shi L, Nauman E, Katzmarzyk P, Price-Haywood E, Bazzano A . Association between Hemoglobin A1c and Stroke Risk in Patients with Type 2 Diabetes. J Stroke. 2020; 22(1):87-98. PMC: 7005352. DOI: 10.5853/jos.2019.01704. View

Adams Jr H, Bendixen B, Kappelle L, Biller J, Love B, Gordon D . Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993; 24(1):35-41. DOI: 10.1161/01.str.24.1.35. View

Zhang Y, Guo L, Zhu H, Jiang L, Xu L, Wang D . Effects of the stress hyperglycemia ratio on long-term mortality in patients with triple-vessel disease and acute coronary syndrome. Cardiovasc Diabetol. 2024; 23(1):143. PMC: 11046747. DOI: 10.1186/s12933-024-02220-3. View

Xie E, Ye Z, Wu Y, Zhao X, Li Y, Shen N . Predictive value of the stress hyperglycemia ratio in dialysis patients with acute coronary syndrome: insights from a multi-center observational study. Cardiovasc Diabetol. 2023; 22(1):288. PMC: 10612265. DOI: 10.1186/s12933-023-02036-7. View

Chen X, Liu Z, Miao J, Zheng W, Yang Q, Ye X . High Stress Hyperglycemia Ratio Predicts Poor Outcome after Mechanical Thrombectomy for Ischemic Stroke. J Stroke Cerebrovasc Dis. 2019; 28(6):1668-1673. DOI: 10.1016/j.jstrokecerebrovasdis.2019.02.022. View

Smith C, Emsley H, Gavin C, Georgiou R, Vail A, Barberan E . Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome. BMC Neurol. 2004; 4:2. PMC: 331413. DOI: 10.1186/1471-2377-4-2. View

Shen D, Cai X, Zhu Q, Heizhati M, Hu J, Song S . Increased stress hyperglycemia ratio at hospital admission in stroke patients are associated with increased in-hospital mortality and length of stay. Diabetol Metab Syndr. 2024; 16(1):69. PMC: 10943784. DOI: 10.1186/s13098-024-01303-1. View

Touboul P, Hennerici M, Meairs S, Adams H, Amarenco P, Bornstein N . Mannheim carotid intima-media thickness and plaque consensus (2004-2006-2011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany,.... Cerebrovasc Dis. 2012; 34(4):290-6. PMC: 3760791. DOI: 10.1159/000343145. View

10.

Walter K . What Is Acute Ischemic Stroke?. JAMA. 2022; 327(9):885. DOI: 10.1001/jama.2022.1420. View

11.

Korompoki E, Ntaios G, Tountopoulou A, Mavraganis G, Tsampalas E, Kalliontzakis I . Quality Indicators and Clinical Outcomes of Acute Stroke: Results from a Prospective Multicenter Registry in Greece (SUN4P). J Clin Med. 2024; 13(3). PMC: 10856279. DOI: 10.3390/jcm13030917. View

12.

Yuan C, Chen S, Ruan Y, Liu Y, Cheng H, Zeng Y . The Stress Hyperglycemia Ratio is Associated with Hemorrhagic Transformation in Patients with Acute Ischemic Stroke. Clin Interv Aging. 2021; 16:431-442. PMC: 7955757. DOI: 10.2147/CIA.S280808. View

13.

Jeong J, Park J, Koh Y, Park J, Bae H, Yun S . Association of HbA1c with functional outcome by ischemic stroke subtypes and age. Front Neurol. 2023; 14:1247693. PMC: 10568315. DOI: 10.3389/fneur.2023.1247693. View

14.

Zhou M, Wang H, Zeng X, Yin P, Zhu J, Chen W . Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2019; 394(10204):1145-1158. PMC: 6891889. DOI: 10.1016/S0140-6736(19)30427-1. View

15.

Sharma A, Pandit A, Mishra B, Srivastava M, Srivastava A, Vishnu V . Early neurological deterioration in acute ischemic stroke. Ir J Med Sci. 2023; 193(2):949-955. DOI: 10.1007/s11845-023-03485-5. View

16.

Jiang Z, Wang K, Duan H, Du H, Gao S, Chen J . Association between stress hyperglycemia ratio and prognosis in acute ischemic stroke: a systematic review and meta-analysis. BMC Neurol. 2024; 24(1):13. PMC: 10759321. DOI: 10.1186/s12883-023-03519-6. View

17.

Han L, Hou Z, Ma M, Ding D, Wang D, Fang Q . Impact of glycosylated hemoglobin on early neurological deterioration in acute mild ischemic stroke patients treated with intravenous thrombolysis. Front Aging Neurosci. 2023; 14:1073267. PMC: 9877605. DOI: 10.3389/fnagi.2022.1073267. View

18.

Mendelson S, Prabhakaran S . Diagnosis and Management of Transient Ischemic Attack and Acute Ischemic Stroke: A Review. JAMA. 2021; 325(11):1088-1098. DOI: 10.1001/jama.2020.26867. View

19.

Pandolfi A, Iacoviello L, Capani F, Vitacolonna E, Donati M, Consoli A . Glucose and insulin independently reduce the fibrinolytic potential of human vascular smooth muscle cells in culture. Diabetologia. 1996; 39(12):1425-31. DOI: 10.1007/s001250050594. View

20.

Lau L, Lew J, Borschmann K, Thijs V, Ekinci E . Prevalence of diabetes and its effects on stroke outcomes: A meta-analysis and literature review. J Diabetes Investig. 2018; 10(3):780-792. PMC: 6497593. DOI: 10.1111/jdi.12932. View